Our Mission

Suono Bio is on a mission to revolutionize what therapeutics may be used to treat diseases. Advances in genomics have enabled a step-shift in our understanding of diseases and relevant targets to treat those diseases but delivery technologies lag. Our technology promises to deliver potentially superior therapies, like nucleic acids and gene therapies, in a simplified proprietary formulation. Suono Bio’s mission is to enable the use of the right drug at the right location in the right patient.

Meet the Team

Founders

Robert Langer, ScD
Co-​Founder

Gio Traverso, MD, PHD
Co-Founder

Carl Schoellhammer, PhD
Co-Founder, CTO

Management​

Scott Kellogg, MS, MBA
CEO

Sean Moran, CPA
Senior Management Advisor

Albert "Skip" Farinha
COO

Molly Dunham-Friel, MPH
Patient Advocacy Advisor

Carl Schoellhammer, PhD
Co-Founder, CTO

Harry Martins
VP, Engineering and New
Product Development

Tuan Elstrom
Senior New Business
​Development Lead

Board of Directors

Fred Shane
Managing Partner, Axil Capital

Robert Langer, ScD
Co-​Founder, Suono Bio

Gio Traverso, MD, PHD
Co-Founder, Suono Bio

Carl Schoellhammer, PhD
Co-Founder, CTO, Suono Bio

Scott Kellogg, MS, MBA
CEO, Suono Bio

Victoria Wang
Investment Principal
​Taiwania Capital

Medical Advisory Board

Kenolisa Onwueme, MD, PhD
Chair, Division of Gastroenterology
University of Maryland-Baltimore Washington Medical Center

Jakob Begun, MD, PhD
Director of Gastroenterology,
​Mater Hospital Brisbane

Scott Snapper
Chief, Division of Gastroenterology, Hepatology, and Nutrition
Boston Children's Hospital

David Feigal, MD
Partner, NDA Partners